Ending Parkinson’s disease: The path is getting shorter
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement, resulting most notably in tremor, slow movement, stiffness and balance issues. While Parkinson’s patients benefit from medicine that can alleviate some of these symptoms, there are no available treatments to slow, halt or reverse the progressive destruction of dopamine-producing brain cells and abnormal clumping of alpha synuclein, an otherwise normal brain protein. The disease affects roughly 10 million people …